Scholars@Duke publication: The Influence of the Tumor Microenvironment on Checkpoint Inhibitor Efficacy: Lessons Learned from Targeting the TGF-β Signaling Pathway.

The Influence of the Tumor Microenvironment on Checkpoint Inhibitor Efficacy: Lessons Learned from Targeting the TGF-β Signaling Pathway.

Publication , Conference

Hanks, BA

Duke Scholars

Author Brent A. Hanks Medicine, Medical Oncology

Location

Washington, DC

Conference Name

2016 Melanoma Research Alliance Annual Meeting

Citation

APA

Chicago

ICMJE

MLA

NLM

Hanks, B. A. (n.d.). The Influence of the Tumor Microenvironment on Checkpoint Inhibitor Efficacy: Lessons Learned from Targeting the TGF-β Signaling Pathway. Presented at the 2016 Melanoma Research Alliance Annual Meeting, Washington, DC.

Hanks, B. A. “The Influence of the Tumor Microenvironment on Checkpoint Inhibitor Efficacy: Lessons Learned from Targeting the TGF-β Signaling Pathway.,” n.d.

Hanks BA. The Influence of the Tumor Microenvironment on Checkpoint Inhibitor Efficacy: Lessons Learned from Targeting the TGF-β Signaling Pathway. In.

Hanks, B. A. The Influence of the Tumor Microenvironment on Checkpoint Inhibitor Efficacy: Lessons Learned from Targeting the TGF-β Signaling Pathway.

Hanks BA. The Influence of the Tumor Microenvironment on Checkpoint Inhibitor Efficacy: Lessons Learned from Targeting the TGF-β Signaling Pathway.

Location

Washington, DC

Conference Name

2016 Melanoma Research Alliance Annual Meeting